Article

PRODUCT SPECTRUM

MENICON AMERICA LAUNCHES MIRU 1MONTH MENICON IN THE UNITED STATES

Menicon America now offers in the United States Miru 1month Menicon, a monthly replacement silicone hydrogel lens in spherical, toric, and multifocal designs. Reformulated for the U.S. market, Miru 1month Menicon obtained U.S. Food and Drug Administration approval in Feb. 2018.

Miru 1month features unique geometry to control and minimize lens thickness across the whole lens surface and the entire power range, according to Menicon. Moreover, the Miru 1month toric has a prism-free optic zone and an asymmetric Thin Zones profile to help maximize oxygen transmissibility over the cornea. Menicon says that the Thin Zones design also optimizes centration and minimizes rotation.

The Miru 1month family utilizes proprietary MeniSilk and Nanogloss technologies to achieve high wettability and excellent anti-fouling properties against surface contaminants while maintaining satisfactory oxygen permeability, according to the company. A unique edge profile is designed to provide uniform comfort regardless of lens power.

The lens is manufactured in asmofilcon A, which has a water content of 40% and a reported Dk/t at –3.00D of 161. Sphere lens parameters include 8.3mm and 8.6mm base curves, 14.0mm diameter, and powers of +6.00D to –6.00D (0.25D steps) and –6.50D to –13.00D (0.50D steps), no plano available. Toric lens parameters include 8.6mm base curve, 14.0mm diameter, sphere powers of plano to –6.00D (0.25D steps) and –6.50D to –10.00D (0.50D steps), and cylinders of –0.75D, –1.25D, and –1.75D in axes of 10º to 180º (10º steps). Multifocal lens parameters include 8.6mm base curve, 14.2mm diameter, sphere powers of +6.00D to –6.00D (0.25D steps) and –6.50D to –13.00D (0.50D steps), and a Low add power. All three designs have a center thickness of 0.08mm at –3.00D. Call (800) 636-4266 or visit www.meniconamerica.com/pro .

Miru 1month Menicon is now available in the U.S. market.

VIRTUAL FIELD ANNOUNCES VISUAL FIELD TEST FOR VR HEADSETS

Virtual Field, Inc. launched its virtual reality platform for diagnostic eye exams. The product, which consists of a VR headset, computer, and clicker, runs Standard 24-2 and suprathreshold visual field tests. The company is also developing 10-2, 30-2, kinetic, and frequency doubling tests for its headset, which will be released as updates to its platform. Unlike conventional devices, which require an eye patch to be worn on the opposite eye during testing, Virtual Field tests both eyes simultaneously, without the need for an eye patch. It also features fixation and sleep monitoring features that reduce invalid test results, according to the company. Call (760) 613-4364 or visit www.virtualfield.io .

FOCUS LABORATORIES OFFERS NEW SUPPLEMENT AND LID HYGIENE FOR DRY EYE

Focus Laboratories recently launched the VitaSight O3+Maqui nutritional supplement and Zenoptiq Hypochlorous Acid Solution for daily eyelid and lash cleansing.

Focus says that the VitaSight O3+Maqui combines two key ingredients, omega-3 and maqui berry, to support eye health and promote healthy tear production. O3+Maqui contains 2,745mg of purified, highly refined omega-3 fish oil in a re-esterified triglyceride form. O3+Maqui softgels are made with Unigel technology, the only patented technology that offers the combination of a liquid and powder tablet in one softgel, according to Focus.

Zenoptiq (manufactured for Paragon BioTeck) Hypochlorous Acid Solution is a natural cleansing agent in a non-prescription-strength formula, according to the company. Focus says that it gently cleanses eyelids, removing debris that may cause blockage of the glands. Hypochlorous acid kills bacteria and may reduce inflammation, giving patients relief from symptoms associated with meibomian gland dysfunction, according to the company. Zenoptiq is available in a 0.01% spray and in a 0.0085% gel. Call (866) 752-6006 or visit shopfocuslaboratories.com .